| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Empagliflozin |
| Brand | Jardiance® |
| Indication | Add-on combination therapy: In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control. Monotherapy: When diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance. |
| Assessment Process | |
| Rapid review commissioned | 22/05/2014 |
| Rapid review completed | 12/06/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |
